Welldoc Inc.’s smartphone app for the treatment of patients with diabetes is moving into a new phase of research at a Massachusetts primary care practice.
The testing of the Columbia company’s BlueStar app is going into phase two of quality improvement research at The Ambulatory Practice of the Future at Massachusetts General Hospital in Boston. Dr. Daniel Henderson of is leading the research, the company announced.
The app coaches patients with personalized, real-time feedback and tools to engage patients with diabetes and hypertension. It also provides data to the health care team.
Henderson said in a news release that he would look at the app’s impact on patient care as well as burden reduction for health providers and administrative staff.